santa cruz biotechnology, inc.
SCBT Logo

Willkommen!        Produkt(e) im Warenkorb.     Bestellen
 

Cytochrome P-450 Inhibitors and Inducers

  • 1-Aminobenzotriazole
    A suicide substrate for cytochrome P-450 and chloroperoxidase, shown to inhibit oxidative drug metabolism in vivo and block ω-oxidation of arachidonic acid but not epoxidation.
    Katalog #CAS NummerSummenformelMenge
    sc-2006001614-12-6C6H6N420 mg/100 mg
  • (±)11(12)-EET
    Biosynthesized in rat and rabbit liver microsomes by CYP450. Has been shown, along with (±)8(9)-EET, to play a role in the recovery of depleted Ca2+ pools in cultured smooth muscle cells.
    Katalog #CAS NummerSummenformelMenge
    sc-22057981276-02-0C20H32O325 µg/50 µg
  • (±)14(15)-EET
    Biosynthesized in rat and rabbit liver microsomes by CYP450.1,2 Dramatic increases in urinary (±)14,15-DiHETrE, which is a (±)14(15)-EET metabolite, have been documented by GC/MS in pregnancy induced hypertension.3
    Katalog #CAS NummerSummenformelMenge
    sc-220610n.n.C20H32O325 µg/50 µg
  • (±)14(15)-EET Ethanolamide
    An endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. Fatty acid amide hydrolase (FAAH) is the enzyme responsible for the hydrolysis and inactivation of AEA. Metabolism of AEA by cyclooxygenase-2, leading to formation of prostaglandin ethanolamides and by lipoxygenases has also been documented. (±)14(15)-EET ethanolamide is a potential cytochrome P450 (CYP450) metabolite of AEA, although specific stereochemistry rather than a racemic mixture would likely ensue from enzymatic metabolism. CYP450 metabolism of AEA may be particularly relevant under conditions of FAAH inhibition. Evidence for the formation of (±)14(15)-EET ethanolamide in vivo has not been documented.
    Katalog #CAS NummerSummenformelMenge
    sc-220611n.n.C22H37NO325 µg/50 µg
  • 16(17)-EpDPE
    An unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators. Cytochrome P450 (CYP450) metabolism of polyunsaturated fatty acids produces epoxides such as 14(15)-EpETrE which are prime candidates for the actual active mediator. However, the CYP450 metabolites of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been little studied relative to arachidonate epoxygenase metabolites. Is the DHA homolog of 14(15)-EpETrE, derived via epoxidation of the 16,17-double bond of docosahexaenoic acid (DHA). The EDHF activity of 16(17)-EpDPE has not yet been determined and the epoxygenase metabolites of DHA have also been detected in a murine inflammation model.
    Katalog #CAS NummerSummenformelMenge
    sc-220642n.n.C22H32O325 µg/50 µg
  • 2,3-dihydrothieno-Thiadiazole Carboxylate
    1,2,3-Thiadiazoles are used in agriculture and medicine applications, such as bactericides, fungicides, and antiviral agents. 2,3-dihydrothieno-Thiadiazole carboxylate (MTCC), 100 µM, inactivates and inhibits certain microsomal CYP450 enzymes (CYP2E1 and CYP2B4), but not others (CYP1A2), with inactivation occurring in a mechanism-based manner.
    Katalog #CAS NummerSummenformelMenge
    sc-220770n.n.C6H4N2O2S250 mg/100 mg
  • 4,5-diphenyl-1,2,3-Thiadiazole
    Has diverse applications in medicine and agriculture, including as bactericides, fungicides, and antiviral agents. At 100 μM, an inhibitor of some CYP450 enzymes (CYP2B4, CYP1A2), but not others (CYP2E1), with inhibition occurring in a mechanism-based manner.
    Katalog #CAS NummerSummenformelMenge
    sc-2051275393-99-7C14H10N2S250 mg/500 mg
  • 6',7'-dihydroxy Bergamottin
    A potent inhibitor of CYP3A4; appears to be the primary compound in grapefruit juice that is responsible for inhibition of testosterone 6β-hydrolase activity.
    Katalog #CAS NummerSummenformelMenge
    sc-205162145414-76-2C21H24O61 mg/10 mg
  • 7-Ethoxyresorufin
    Fluorimetric substrate and suicide inhibitor for cytochrome P450, nitric oxide synthesis inhibitor, NADPH-P450 inhibitor, with demonstrated inhibition of vasorelaxant responses to acetylcholine.
    Katalog #CAS NummerSummenformelMenge
    sc-2006065725-91-7C14H11NO32 mg/10 mg
  • Benzylimidazole
    Found to induce various cytochrome P-450 isozymes and to inhibit thromboxane A2 synthase.
    Katalog #CAS NummerSummenformelMenge
    sc-2005304238-71-5C10H10N21 g/5 g
  • β-Naphthoflavone
    Cytochrome P450 enzyme system inducer. Protects chemical-induced carcinogenesis by enhancing the detoxification of carcinogens.
    Katalog #CAS NummerSummenformelMenge
    sc-2055976051-87-2C19H12O21 g/5 g
  • Clofibrate
    A ligand agonist for peroxisome proliferator-activated receptor α (PPARα) and influences expression of cytochromes P450IVA1 and IVA3 in studies with rat liver.
    Katalog #CAS NummerSummenformelMenge
    sc-200721637-07-0C12H15ClO31 g
  • Feprazone
    A non-steroidal, anti-inflammatory compound reported to induce the cytochrome P-450 II B family of cytochromes.
    Katalog #CAS NummerSummenformelMenge
    sc-27916230748-29-9C20H20N2O2200 mg
  • Furafylline
    A methyl xanthine derivative with an expanded duration of action than theophylline and it is an inhibitor of cytochrome P4501A2.
    Katalog #CAS NummerSummenformelMenge
    sc-21506180288-49-9C12H12N4O35 mg
  • HET-0016
    A potent and selective inhibitor of the biosynthesis of 20-HETE in human renal microsomes with an IC50 of 8.9 nM, selectively inhibiting CYP4A and 4F isoforms.
    Katalog #CAS NummerSummenformelMenge
    sc-200673339068-25-6C12H18N2O5 mg/25 mg
  • Ketoconazole
    An inhibitor of thromboxane synthetase and 5-lipoxygenase. Suppresses 5-lipoxygenase-mediated production of leukotrienes. Reduces production of thromboxane A2. Inhibits adrenocorticoid biosynthesis.
    Katalog #CAS NummerSummenformelMenge
    sc-20049665277-42-1C26H28Cl2N4O450 mg/500 mg
  • Methoxsalen (8-Methoxypsoralen)
    A potent tricyclic fumocoumarin suicide inhibitor of cytochrome P-450.
    Katalog #CAS NummerSummenformelMenge
    sc-200505298-81-7C12H8O41 g
  • Metyrapone
    Inhibits the biosynthesis of corticosteroid. Reported to rapidly oxidize endogenous NADPH, improve oxidation of cortisol, and inhibit the reduction of cortisone.
    Katalog #CAS NummerSummenformelMenge
    sc-20059754-36-4C14H14N2O200 mg
  • MS-PPOH
    A selective inhibitor of the epoxygenation reactions catalyzed by specific CYP450 isozymes.
    Katalog #CAS NummerSummenformelMenge
    sc-205392206052-02-0C16H21NO4S1 mg/5 mg
  • Muscone
    Has been shown to induce CYP4F3 and contain antiinflammatory effects by reducing proinflammatory cytokines. Also reported to be weakly estrogenically active in vitro.
    Katalog #CAS NummerSummenformelMenge
    sc-200528541-91-3C16H30O100 mg/500 mg
  • Naringenin-4'-O-beta-D-Glucuronide
    Naringenin is a flavanone. Naringenin-4'-O-β-D-Glucuronide is the metabolite of the flavonoid naringin, which has been shown to have an inhibitory effect on the human cytochrome P450 isoform CYP1A2.
    Katalog #CAS NummerSummenformelMenge
    sc-295905158196-35-1C21H20O11100 µg/500 µg
  • Rutaecarpine
    An alkaloid isolated from the chinese herb Evodia rutaecarpa which has vasorelaxing effect andinhibits platelet aggregation and COX-2. This compound is a selective inhibitor of cytochrome P450 1A.
    Katalog #CAS NummerSummenformelMenge
    sc-20584684-26-4C18H13N3O10 mg/25 mg
  • SKF-525A HCl (Proadifen)
    Exhibits a wide array of activity, including: inhibition of NOS1, AChR, CYP4, transmembrane Ca2+ influx, and platelet thromboxane synthesis, as well as blockage of KIR6.1, and stimulation of endothelial cell prostacyclin production.
    Katalog #CAS NummerSummenformelMenge
    sc-20049262-68-0C23H32ClNO2250 mg/1 g
  • YM 511
    Katalog #CAS NummerSummenformelMenge
    sc-361413148869-05-0C16H12BrN510 mg/50 mg